Skip to content

A Comparative Study of the Effectiveness of Two Analgesic Medications Used for Pain Control During Sedation

The comparison of the efficacy of remifentanil and sufentanil in monitored anesthesia care: Randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0012415
Enrollment
68
Registered
2026-08-07
Start date
2026-08-18
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Participants will be randomized in a 1:1 ratio to receive monitored anesthesia care (MAC) with remimazolam combined with either sufentanil or remifentanil. Remifentanil and sufentanil will be a

Sponsors

Seoul National University Bundang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients aged =19 years undergoing surgery under monitored anesthesia care (MAC)

Exclusion criteria

Exclusion criteria: Preexisting renal or hepatic dysfunction Pregnancy Known hypersensitivity or adverse reactions to remimazolam, remifentanil, or sufentanil

Design outcomes

Primary

MeasureTime frame
surgical condition

Secondary

MeasureTime frame
Incidence of intraoperative hypotension and apnea;Postoperative pain score ;Incidence of nausea and vomiting during the recovery period;Analgesic consumption in the PACU;Administration of reversal agents (flumazenil and naloxone);ncidence of unplanned events requiring conversion to general anesthesia or unplanned admission;Patient satisfaction with the overall anesthesia experience

Countries

Korea, Republic of

Contacts

Public ContactJiyoun Lee

Seoul National University Bundang Hospital

heykiki1@hanmail.net+82-31-787-7499

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Aug 25, 2026